Merck said on Wednesday that its experimental oral HIV treatment was not inferior to Gilead's top-selling HIV drug Biktarvy ...

Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...

Last year, 444 people in the Netherlands were diagnosed with HIV, the virus that can cause AIDS. Almost 20 years ago, there ...

New diagnoses of HIV and syphilis have doubled in Florida since 2020. St. Lucie County has the highest rate of new HIV cases ...

Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term.

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

THERE’S been an “alarming” increase in HIV infections among straight women, a new report warns. It comes as sexual health ...

Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at ...

Merck said on Wednesday that its experimental oral HIV treatment met the main goal of a late-stage trial. The company said ...

In people with HIV infection aged 60 years or older, the long-acting cabotegravir and rilpivirine combination maintains high ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

China has announced a US$3.49 million (R60 million) partnership with South Africa to expand HIV prevention services among adolescents and young people, as ...